The Enterprise Value as of November 2024 (TTM) for Beam Therapeutics Inc. (BEAM) is 2.01B

According to Beam Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.01B. This represents a change of -2.23% compared to the average of 2.05B of the last 4 quarters.

Beam Therapeutics Inc. (BEAM) Historical Enterprise Value (quarterly & annually)

How has BEAM Enterprise Value performed in the past?

The mean historical Enterprise Value of Beam Therapeutics Inc. over the last ten years is 2.04B. The current 2.01B Enterprise Value has changed 9.74% with respect to the historical average. Over the past ten years (40 quarters), BEAM's Enterprise Value was at its highest in in the June 2021 quarter at 7.93B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

Beam Therapeutics Inc. (BEAM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Beam Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Beam Therapeutics Inc. (BEAM) Average Enterprise Value

How has BEAM Enterprise Value performed in the past?

The current Enterprise Value of Beam Therapeutics Inc. (BEAM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Beam Therapeutics Inc. (BEAM) Enterprise Value vs. Peers

How is BEAM’s Enterprise Value compared to its peers?

Beam Therapeutics Inc.’s Enterprise Value is greater than Editas Medicine, Inc. (144.07M), less than CRISPR Therapeutics AG (4.09B), greater than Caribou Biosciences, Inc. (177.59M), greater than Verve Therapeutics, Inc. (323.17M), greater than Intellia Therapeutics, Inc. (1.44B), greater than Fate Therapeutics, Inc. (321.89M), greater than Prime Medicine, Inc. (342.99M), less than Vertex Pharmaceuticals Incorporated (112.60B), greater than Ginkgo Bioworks Holdings, Inc. (242.08M), greater than Sana Biotechnology, Inc. (551.82M),

Build a custom stock screener for Beam Therapeutics Inc. (BEAM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Beam Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Beam Therapeutics Inc. (BEAM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Beam Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.